26 April 2017
Washington DC
Reporter: Barney Dixon

Patent dance question to be heard today


The US Supreme Court will today (26 April) hear oral arguments in the highly anticipated Amgen v Sandoz litigation on the patent dance procedure.

A decision in favour of Sandoz could lead to a new definition of the patent dance procedures contained in the Biologics Price Competition and Innovation Act (BPCIA).

Amgen asked the Supreme Court whether biosimilar applicants must adhere to the BPCIA’s two-stage process that requires applicants to file an Abbreviated Biologics License Application along with providing the patent owner with information about the applicant’s manufacturing process, otherwise known as the ‘patent dance’.

Applicants then have 180 days to provide the patent owner with notice of Food and Drug Administration (FDA) approval.

Brendan O’Malley, partner at Fitzpatrick, Cella, Harper & Scinto, commented: “Reference product sponsors believe a reversal on this question would lead to chaos, in part because they would have no way to predict when a launch might be imminent, making it difficult to obtain a preliminary injunction before the biosimilars enter the market.”

The Supreme Court also faces a separate question from Sandoz, which asks whether the notice of commercial marketing can be effective in general.

O’Malley said that an affirmation on this question could be a reference sponsor’s sole mechanism for patent enforcement if the biosimilar applicant declines to engage in the patent dance.

“A reversal on this question could help to restore reference product sponsors’ expectation that an early and orderly pathway would exist for enforcing their patent rights.”

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Patent owners winning in IPR
12 December 2017 | New York | Reporter: Barney Dixon
Patent owners are winning more than losing in IPR proceedings, according to a study from law firm Fitzpatrick, Cella, Harper & Scinto
High tech companies weigh in on Allergan deal
11 December 2017 | Washington DC | Reporter: Barney Dixon
Tech companies have argued that Allergan should not be allowed to circumvent the inter partes review process with its controversial patent deal with the Saint Regis Mohawk Tribe
BlackBerry to pay $137 million to Nokia
08 December 2017 | Waterloo | Reporter: Barney Dixon
BlackBerry will pay $137 million to Nokia after the International Chamber of Commerce’s International Court of Arbitration ruled against the company in a patent licensing dispute
ILO ruling “vote of no confidence” for Battistelli, says CSC
07 December 2017 | Munich | Reporter: Barney Dixon
In an open letter to the EPO’s heads of delegations, the CSC said that it interpreted the ILO’s decision as a “massive vote of no confidence in the president of the EPO"
China world’s top patent filer in 2016
07 December 2017 | Geneva | Reporter: Barney Dixon
China has emerged as the top patent filer in the world, accounting for nearly all of the 8 percent growth in patent applications in 2016
EPO president’s impartiality questioned at ILO
06 December 2017 | Geneva | Reporter: Barney Dixon
The International Labour Organisation has questioned the impartiality of EPO president Benoît Battistelli, in two tribunal decisions concerning an EPO employee, and found that there was a conflict of interest on the part of the president
Squire Patton Boggs hires ex Walgreens Boots Alliance counsel
06 December 2017 | London | Reporter: Barney Dixon
Squire Patton Boggs has appointed Kerry Lee as partner in its intellectual property and technology practice